Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety - Quiz - MDSpire

Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety

  • By

  • Yaping Quan

  • Zhengjie Liang

  • Yunhao Wei

  • Hao Li

  • Yan Zeng

  • Jie Shen

  • Shengfa Su

  • Xian Liu

  • Zhongjun Huang

  • Minfang Wang

  • Hongyan Luo

  • Yong Hu

  • Jie Peng

  • July 15, 2026

Share

Original Source(s)

Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety

  • by Yaping Quan, Zhengjie Liang, Yunhao Wei, Hao Li, Yan Zeng, Jie Shen, Shengfa Su, Xian Liu, Zhongjun Huang, Minfang Wang, Hongyan Luo, Yong Hu, Jie Peng

  • July 15, 2026

Related Content

Circular RNA circEVI5 functions as a miR-433 sponge to promote renal cell carcinoma progression via GBP2-mediated oncogenic signaling

Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review

Case Report: Preoperative embolization for a large intracranial pheochromocytoma metastasis: a novel approach to minimize intraoperative risk